Cargando…
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH
Octamer transcription factor 1 (OCT1) is a transcriptional factor reported to be a poor prognostic factor in various cancers. However, the clinical value of OCT1 in breast cancer is not fully understood. In the present study, an immunohistochemical study of OCT1 protein was performed using estrogen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584020/ https://www.ncbi.nlm.nih.gov/pubmed/34768935 http://dx.doi.org/10.3390/ijms222111505 |
_version_ | 1784597344922107904 |
---|---|
author | Ogura, Takuya Azuma, Kotaro Sato, Junichiro Kinowaki, Keiichi Takayama, Ken-Ichi Takeiwa, Toshihiko Kawabata, Hidetaka Inoue, Satoshi |
author_facet | Ogura, Takuya Azuma, Kotaro Sato, Junichiro Kinowaki, Keiichi Takayama, Ken-Ichi Takeiwa, Toshihiko Kawabata, Hidetaka Inoue, Satoshi |
author_sort | Ogura, Takuya |
collection | PubMed |
description | Octamer transcription factor 1 (OCT1) is a transcriptional factor reported to be a poor prognostic factor in various cancers. However, the clinical value of OCT1 in breast cancer is not fully understood. In the present study, an immunohistochemical study of OCT1 protein was performed using estrogen receptor (ER)-positive breast cancer tissues from 108 patients. Positive OCT1 immunoreactivity (IR) was associated with the shorter disease-free survival (DFS) of patients (p = 0.019). Knockdown of OCT1 inhibited cell proliferation in MCF-7 breast cancer cells as well as its derivative long-term estrogen-deprived (LTED) cells. On the other hand, the overexpression of OCT1 promoted cell proliferation in MCF-7 cells. Using microarray analysis, we identified the non-structural maintenance of chromosomes condensin I complex subunit H (NCAPH) as a novel OCT1-taget gene in MCF-7 cells. Immunohistochemical analysis showed that NCAPH IR was significantly positively associated with OCT1 IR (p < 0.001) and that positive NCAPH IR was significantly related to the poor DFS rate of patients (p = 0.041). The knockdown of NCAPH inhibited cell proliferation in MCF-7 and LTED cells. These results demonstrate that OCT1 and its target gene NCAPH are poor prognostic factors and potential therapeutic targets for patients with ER-positive breast cancer. |
format | Online Article Text |
id | pubmed-8584020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85840202021-11-12 OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH Ogura, Takuya Azuma, Kotaro Sato, Junichiro Kinowaki, Keiichi Takayama, Ken-Ichi Takeiwa, Toshihiko Kawabata, Hidetaka Inoue, Satoshi Int J Mol Sci Article Octamer transcription factor 1 (OCT1) is a transcriptional factor reported to be a poor prognostic factor in various cancers. However, the clinical value of OCT1 in breast cancer is not fully understood. In the present study, an immunohistochemical study of OCT1 protein was performed using estrogen receptor (ER)-positive breast cancer tissues from 108 patients. Positive OCT1 immunoreactivity (IR) was associated with the shorter disease-free survival (DFS) of patients (p = 0.019). Knockdown of OCT1 inhibited cell proliferation in MCF-7 breast cancer cells as well as its derivative long-term estrogen-deprived (LTED) cells. On the other hand, the overexpression of OCT1 promoted cell proliferation in MCF-7 cells. Using microarray analysis, we identified the non-structural maintenance of chromosomes condensin I complex subunit H (NCAPH) as a novel OCT1-taget gene in MCF-7 cells. Immunohistochemical analysis showed that NCAPH IR was significantly positively associated with OCT1 IR (p < 0.001) and that positive NCAPH IR was significantly related to the poor DFS rate of patients (p = 0.041). The knockdown of NCAPH inhibited cell proliferation in MCF-7 and LTED cells. These results demonstrate that OCT1 and its target gene NCAPH are poor prognostic factors and potential therapeutic targets for patients with ER-positive breast cancer. MDPI 2021-10-25 /pmc/articles/PMC8584020/ /pubmed/34768935 http://dx.doi.org/10.3390/ijms222111505 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ogura, Takuya Azuma, Kotaro Sato, Junichiro Kinowaki, Keiichi Takayama, Ken-Ichi Takeiwa, Toshihiko Kawabata, Hidetaka Inoue, Satoshi OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title | OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title_full | OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title_fullStr | OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title_full_unstemmed | OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title_short | OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH |
title_sort | oct1 is a poor prognostic factor for breast cancer patients and promotes cell proliferation via inducing ncaph |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584020/ https://www.ncbi.nlm.nih.gov/pubmed/34768935 http://dx.doi.org/10.3390/ijms222111505 |
work_keys_str_mv | AT oguratakuya oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT azumakotaro oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT satojunichiro oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT kinowakikeiichi oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT takayamakenichi oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT takeiwatoshihiko oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT kawabatahidetaka oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph AT inouesatoshi oct1isapoorprognosticfactorforbreastcancerpatientsandpromotescellproliferationviainducingncaph |